Bertrand Le Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bertrand Le Roy has a total of 184 co-authors. Here are the top co-authors by number of shared publications:
Denis Pezet
UMR6602, Endoscopy and Computer Vision Group, Faculté de Médecine, Institut Pascal, Clermont-Ferrand, France
6 shared publicationsE. Buc
UMR6602, Endoscopy and Computer Vision group, faculté de médecine, institut Pascal, bâtiment 3C, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France; Department of Digestive and Hepatobiliary Surgery, Hospital Estaing, CHU de Clermont-Ferrand, 1, place Lucie-et-Raymond-Aubrac, 63003 Clermont-Ferrand cedex, France
6 shared publicationsEmmanuel Buc
UMR6602, Endoscopy and Computer Vision Group, Faculté de Médecine, Institut Pascal, Clermont-Ferrand, France
6 shared publicationsJ. Gagnière
Department of Digestive Surgery, Service de Chirurgie Digestive Et Hépato-Biliaire, CHU Estaing, 2, Place Lucie Aubrac, 63000, Clermont-Ferrand, France
6 shared publicationsJohan Gagnière
Department of Digestive and Hepatobiliary Surgery, Hôpital Estaing, CHU Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand, France
6 shared publications- Antonio Sa Cunha
Hepato-Biliary Centre, Paul Brousse, AP-HP, Villejuif, Paris, France
5 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (3)
FRIES score: predicting conversion in robotic liver surgery
- 12 May 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (3)
Open AccessFRIES score: predicting conversion in robotic liver surgery
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Techniques radiovasculaires et d'imagerie dans la prise en charge thérapeutique des tumeurs hépatiques
Introduction. Ce travail consacré à l’apport de l’imagerie diagnostique et interventionnelle dans la prise en charge chirurgicale des tumeurs hépatiques est divisé en deux parties. D’une part, l’imagerie interventionnelle représentée par la biembolisation (embolisation combinée de la veine hépatique droite et de la veine porte droite) et d’autre part l’imagerie diagnostique représentée par la réalité augmentée, avec le logiciel Hepataug conçu par notre groupe composé de scientifiques et chirurgiens. Méthodes1. La biembolisation, a été étudiée suite à un cas de thrombose de TIPS chez un patient cirrhotique ayant entrainée une hypertrophie majeure du foie controlatéral. Après une première analyse de faisabilité sur 7 patients, une étude comparant l’efficacité de la biembolisation par rapport à l’embolisation portale seule des patients éligibles à une hépatectomie majeure.2. Hepataug a initialement été mis en place sur des vidéos d’hépatectomies par la paroscopie en post-opératoire puis étudié en per-opératoire. Pour montrer l’intérêt et le fonctionnement d’Hepataug, nous présentons le cas où le logiciel nous a fait changer notre conduite thérapeutique. Résultats1. Durant la période d’inclusion, 72 patients ont eu une procédure radiologique incluant 41 embolisations portales et 31 biembolisations. L’augmentation moyenne d’hypertrophie du futur foie restant à 3 semaines était de 32 % après embolisation portale et 51 % après biembolisation (p = 0,018). Cette différence reste significative (p = 0,026) en analyse multivariée incluant l’âge, le sexe, l’indice de masse corporelle, le diabète, la cirrhose et la NASH.2. Hepataug a montré que la résection initiale n’était pas complète, nécessitant une deuxième résection. L'histopathologie post-opératoire a confirmé que les marges étaient inférieures à 1mm sur la pièce initiale et supérieure à 1 cm avec la recoupe.Conclusion. La réalité augmentée et la biembolisation sont des techniques d’imagerie et interventionnelle montrant un intérêt et un bénéfice majeur dans la prise en charge chirurgicale des tumeurs hépatiques.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Techniques radiovasculaires et d'imagerie dans la prise en charge thérapeutique des tumeurs hépatiques
Introduction. Ce travail consacré à l’apport de l’imagerie diagnostique et interventionnelle dans la prise en charge chirurgicale des tumeurs hépatiques est divisé en deux parties. D’une part, l’imagerie interventionnelle représentée par la biembolisation (embolisation combinée de la veine hépatique droite et de la veine porte droite) et d’autre part l’imagerie diagnostique représentée par la réalité augmentée, avec le logiciel Hepataug conçu par notre groupe composé de scientifiques et chirurgiens. Méthodes1. La biembolisation, a été étudiée suite à un cas de thrombose de TIPS chez un patient cirrhotique ayant entrainée une hypertrophie majeure du foie controlatéral. Après une première analyse de faisabilité sur 7 patients, une étude comparant l’efficacité de la biembolisation par rapport à l’embolisation portale seule des patients éligibles à une hépatectomie majeure.2. Hepataug a initialement été mis en place sur des vidéos d’hépatectomies par la paroscopie en post-opératoire puis étudié en per-opératoire. Pour montrer l’intérêt et le fonctionnement d’Hepataug, nous présentons le cas où le logiciel nous a fait changer notre conduite thérapeutique. Résultats1. Durant la période d’inclusion, 72 patients ont eu une procédure radiologique incluant 41 embolisations portales et 31 biembolisations. L’augmentation moyenne d’hypertrophie du futur foie restant à 3 semaines était de 32 % après embolisation portale et 51 % après biembolisation (p = 0,018). Cette différence reste significative (p = 0,026) en analyse multivariée incluant l’âge, le sexe, l’indice de masse corporelle, le diabète, la cirrhose et la NASH.2. Hepataug a montré que la résection initiale n’était pas complète, nécessitant une deuxième résection. L'histopathologie post-opératoire a confirmé que les marges étaient inférieures à 1mm sur la pièce initiale et supérieure à 1 cm avec la recoupe.Conclusion. La réalité augmentée et la biembolisation sont des techniques d’imagerie et interventionnelle montrant un intérêt et un bénéfice majeur dans la prise en charge chirurgicale des tumeurs hépatiques.
- 29 October 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Mastering Robotic Liver Resection
Objective: To evaluate the learning curve for robotic liver resection (RLR) in France and determine the impact of procedural frequency on surgical performance (conversion) and postoperative outcomes (complications). Summary Background Data: RLR is increasingly adopted for its ergonomic and technical advantages. However, proficiency in RLR is primarily limited by restricted access to robotic platforms, which hinders consistent case exposure and learning. Understanding how procedural frequency influences learning and outcomes is critical for optimizing training and implementation. Methods: This retrospective multicenter cohort study (FRIES-ACHBPT-2024) included 650 patients who underwent RLR across 10 French hepatobiliary centers (2010–2024). Learning curves were analyzed using cumulative sum (CUSUM) analysis for conversion and blood loss, stratified by procedural complexity (IMM grades 1–3) and recurrence interval (high-frequency: ≤7 days; low-frequency: >7 days). Multivariable logistic regression identified independent predictors of postoperative complications. Results: The conversion rate was 10.8%. Blood loss increased with IMM grade (184 mL for IMM 1, 381 mL for IMM 2, and 753 mL for IMM 3). Learning curve inflection points were reached at 41 cases for conversion and 58 for blood loss. Surgeons with high-frequency access achieved competency earlier (35 vs. 47 cases). Independent predictors of postoperative complications included low-frequency access, age >70, metabolic syndrome, tumor size >5 cm, high IMM grade, and conversion. Conclusions: Frequent access to robotic platforms (at least once a week) facilitates earlier proficiency in RLR and reduces complication risk. Structured training pathways and equitable access are essential to safe and effective RLR adoption.
- 29 October 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Mastering Robotic Liver Resection
Objective: To evaluate the learning curve for robotic liver resection (RLR) in France and determine the impact of procedural frequency on surgical performance (conversion) and postoperative outcomes (complications). Summary Background Data: RLR is increasingly adopted for its ergonomic and technical advantages. However, proficiency in RLR is primarily limited by restricted access to robotic platforms, which hinders consistent case exposure and learning. Understanding how procedural frequency influences learning and outcomes is critical for optimizing training and implementation. Methods: This retrospective multicenter cohort study (FRIES-ACHBPT-2024) included 650 patients who underwent RLR across 10 French hepatobiliary centers (2010–2024). Learning curves were analyzed using cumulative sum (CUSUM) analysis for conversion and blood loss, stratified by procedural complexity (IMM grades 1–3) and recurrence interval (high-frequency: ≤7 days; low-frequency: >7 days). Multivariable logistic regression identified independent predictors of postoperative complications. Results: The conversion rate was 10.8%. Blood loss increased with IMM grade (184 mL for IMM 1, 381 mL for IMM 2, and 753 mL for IMM 3). Learning curve inflection points were reached at 41 cases for conversion and 58 for blood loss. Surgeons with high-frequency access achieved competency earlier (35 vs. 47 cases). Independent predictors of postoperative complications included low-frequency access, age >70, metabolic syndrome, tumor size >5 cm, high IMM grade, and conversion. Conclusions: Frequent access to robotic platforms (at least once a week) facilitates earlier proficiency in RLR and reduces complication risk. Structured training pathways and equitable access are essential to safe and effective RLR adoption.
- Open Access
- 15 February 2025
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 162 (2) , 157-158
Robotic minimally invasive duodenopancreatectomy with superior mesenteric artery approach (with video)
- 15 February 2025
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 162 (2) , 157-158
Open AccessRobotic minimally invasive duodenopancreatectomy with superior mesenteric artery approach (with video)
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 27 (Supplement) , e25
51 Influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine are Highly Cost Effective in Canada
Influenza vaccination with quadrivalent egg-based vaccines (QIVe) in adults ≥ 65 years may be less effective due to immunosenescence. An MF59®-adjuvanted trivalent influenza vaccine (aTIV) has been developed to provide stronger, broader and longer protection in older adults. For the younger age groups, lower effectiveness may be associated to the mutagenesis of influenza viruses that are propagated in eggs. A cell- based quadrivalent influenza vaccine (QIVc) was developed to improve the vaccine effectiveness by eliminating egg-adaptation. The objective of this analysis was to evaluate the potential public health impact on the utilization of both vaccines in Canada. An SEIR dynamic-transmission model was created and adapted to four influenza strains for the 2013-2019 seasons. Strain-specific circulation was obtained from Canada’s national surveillance system. Influenza incidence estimates were calibrated using CDC published data. The model used rVE from peer reviewed publications for QIVc and aTIV showing superiority to QIVe vaccines. Frequency of egg-based genetic changes were estimated from a published review of Crick Institute reports. Estimates of specific vaccines efficacy and economic assumptions were derived from the published literature. Different vaccination scenarios, based on the provincial vaccination programs, were modelled. Replacing QIVe with QIVc in subjects 6 months-64 years led to an annual reduction of 462 156 symptomatic cases; 58 122 GP visits; 40,871 emerging consultations; 3 788 hospitalizations and 662 deaths versus a QIVe-for-all scenario. The adoption of QIVc and aTIV will be highly cost effective over the use of QIVe. aTIV would also be more cost effective than QIVHD. Table 1 provides the detailed results for the others scenario. Sensitivity analyses confirmed the robustness of the assumptions used in the analysis. The greatest public health impact is obtained by using QIVc and aTIV in influenza vaccine programs in Canada versus other combinations of available vaccine.
- 1 October 2022
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 27 (Supplement) , e25
Open Access51 Influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine are Highly Cost Effective in Canada
Influenza vaccination with quadrivalent egg-based vaccines (QIVe) in adults ≥ 65 years may be less effective due to immunosenescence. An MF59®-adjuvanted trivalent influenza vaccine (aTIV) has been developed to provide stronger, broader and longer protection in older adults. For the younger age groups, lower effectiveness may be associated to the mutagenesis of influenza viruses that are propagated in eggs. A cell- based quadrivalent influenza vaccine (QIVc) was developed to improve the vaccine effectiveness by eliminating egg-adaptation. The objective of this analysis was to evaluate the potential public health impact on the utilization of both vaccines in Canada. An SEIR dynamic-transmission model was created and adapted to four influenza strains for the 2013-2019 seasons. Strain-specific circulation was obtained from Canada’s national surveillance system. Influenza incidence estimates were calibrated using CDC published data. The model used rVE from peer reviewed publications for QIVc and aTIV showing superiority to QIVe vaccines. Frequency of egg-based genetic changes were estimated from a published review of Crick Institute reports. Estimates of specific vaccines efficacy and economic assumptions were derived from the published literature. Different vaccination scenarios, based on the provincial vaccination programs, were modelled. Replacing QIVe with QIVc in subjects 6 months-64 years led to an annual reduction of 462 156 symptomatic cases; 58 122 GP visits; 40,871 emerging consultations; 3 788 hospitalizations and 662 deaths versus a QIVe-for-all scenario. The adoption of QIVc and aTIV will be highly cost effective over the use of QIVe. aTIV would also be more cost effective than QIVHD. Table 1 provides the detailed results for the others scenario. Sensitivity analyses confirmed the robustness of the assumptions used in the analysis. The greatest public health impact is obtained by using QIVc and aTIV in influenza vaccine programs in Canada versus other combinations of available vaccine.
- Open Access
- 16 November 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (22) , 12044
Burnout in French General Practitioners: A Nationwide Prospective Study
Background: We aimed to evaluate the prevalence of burnout among French general practitioners in private practice and to study the risk and protective factors of burnout. Methods: A nationwide cross-sectional study was conducted with French GPs working in a private practice in France who were asked to fulfil an internet questionnaire. We used the secure internet application REDCap®. Exclusion criteria were only working in a hospital, substitute doctors, and internship students. There was a putative sample size of 88,886 GPs. We retrieved the Maslach Burnout Inventory (MBI), occupational characteristics (type of installation, emergency regulated shifts, night shifts, university supervisor, weekly hours worked, seniority), and personal characteristics such as age, gender, marital status, and number of children. Results: We included 1926 GPs among the 2602 retrieved questionnaires. A total of 44.8% of French liberal GPs were experiencing burnout, with 4.8% (95%CI 3.9–5.9%) experiencing severe burnout. The risk factors of severe burnout were male gender (RR = 1.91, 95%CI 1.15–3.16), working in a suburban area (5.23, 2.18–12.58), and having more than 28 appointments per day (1.95, 1.19–3.19). Working more than 50 h weekly showed a tendency to increase the risk of severe burnout (1.55, 0.93–2.59, p = 0.095), with a significant increase in the risk of low and moderate burnout (1.31, 1.02–1.67 and 1.86, 1.34–2.57, respectively). Protective factors were mainly resident training, which decreased the risk of both low, moderate, and severe burnout (0.65, 0.51–0.83; 0.66, 0.48–0.92; and 0.42, 95%CI 0.23–0.76, respectively). Performing home visits decreased the risk of severe burnout (0.25, 0.13–0.47), as did group practice for intermediate level of burnout (0.71, 0.51–0.96). Conclusion: GPs are at a high risk of burnout, with nearly half of them in burnout, with burnout predominantly affecting males and those between the ages of 50 and 60 years old. The main risk factors were a high workload with more than 28 appointments per day or 50 h of work per week, and the main protective factors were related to social cohesion such having a teaching role and working in a group practice with back-office support.
- 16 November 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (22) , 12044
Open AccessBurnout in French General Practitioners: A Nationwide Prospective Study
Background: We aimed to evaluate the prevalence of burnout among French general practitioners in private practice and to study the risk and protective factors of burnout. Methods: A nationwide cross-sectional study was conducted with French GPs working in a private practice in France who were asked to fulfil an internet questionnaire. We used the secure internet application REDCap®. Exclusion criteria were only working in a hospital, substitute doctors, and internship students. There was a putative sample size of 88,886 GPs. We retrieved the Maslach Burnout Inventory (MBI), occupational characteristics (type of installation, emergency regulated shifts, night shifts, university supervisor, weekly hours worked, seniority), and personal characteristics such as age, gender, marital status, and number of children. Results: We included 1926 GPs among the 2602 retrieved questionnaires. A total of 44.8% of French liberal GPs were experiencing burnout, with 4.8% (95%CI 3.9–5.9%) experiencing severe burnout. The risk factors of severe burnout were male gender (RR = 1.91, 95%CI 1.15–3.16), working in a suburban area (5.23, 2.18–12.58), and having more than 28 appointments per day (1.95, 1.19–3.19). Working more than 50 h weekly showed a tendency to increase the risk of severe burnout (1.55, 0.93–2.59, p = 0.095), with a significant increase in the risk of low and moderate burnout (1.31, 1.02–1.67 and 1.86, 1.34–2.57, respectively). Protective factors were mainly resident training, which decreased the risk of both low, moderate, and severe burnout (0.65, 0.51–0.83; 0.66, 0.48–0.92; and 0.42, 95%CI 0.23–0.76, respectively). Performing home visits decreased the risk of severe burnout (0.25, 0.13–0.47), as did group practice for intermediate level of burnout (0.71, 0.51–0.96). Conclusion: GPs are at a high risk of burnout, with nearly half of them in burnout, with burnout predominantly affecting males and those between the ages of 50 and 60 years old. The main risk factors were a high workload with more than 28 appointments per day or 50 h of work per week, and the main protective factors were related to social cohesion such having a teaching role and working in a group practice with back-office support.
- 20 July 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (12) , 5642-5648
A case series study of augmented reality in laparoscopic liver resection with a deformable preoperative model
Background Previous work in augmented reality (AR) guidance in monocular laparoscopic hepatectomy requires the surgeon to manually overlay a rigid preoperative model onto a laparoscopy image. This may be fairly inaccurate because of significant liver deformation. We have proposed a technique which overlays a deformable preoperative model semi-automatically onto a laparoscopic image using a new software called Hepataug. The aim of this study is to show the feasibility of Hepataug to perform AR with a deformable model in laparoscopic hepatectomy. Methods We ran Hepataug during the procedures, as well as the usual means of laparoscopic ultrasonography (LUS) and visual inspection of the preoperative CT or MRI. The primary objective was to assess the feasibility of Hepataug, in terms of minimal disruption of the surgical workflow. The secondary objective was to assess the potential benefit of Hepataug, by subjective comparison with LUS. Results From July 2017 to March 2019, 17 consecutive patients were included in this study. AR was feasible in all procedures, with good correlation with LUS. However, for 2 patients, LUS did not reveal the location of the tumors. Hepataug gave a prediction of the tumor locations, which was confirmed and refined by careful inspection of the preoperative CT or MRI. Conclusion Hepataug showed a minimal disruption of the surgical workflow and can thus be feasibly used in real hepatectomy procedures. Thanks to its new mechanism of semi-automatic deformable alignment, Hepataug also showed a good agreement with LUS and visual CT or MRI inspection in subsurface tumor localization. Importantly, Hepataug yields reproducible results. It is easy to use and could be deployed in any existing operating room. Nevertheless, comparative prospective studies are needed to study its efficacy.
- 20 July 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 34 (12) , 5642-5648
A case series study of augmented reality in laparoscopic liver resection with a deformable preoperative model
Background Previous work in augmented reality (AR) guidance in monocular laparoscopic hepatectomy requires the surgeon to manually overlay a rigid preoperative model onto a laparoscopy image. This may be fairly inaccurate because of significant liver deformation. We have proposed a technique which overlays a deformable preoperative model semi-automatically onto a laparoscopic image using a new software called Hepataug. The aim of this study is to show the feasibility of Hepataug to perform AR with a deformable model in laparoscopic hepatectomy. Methods We ran Hepataug during the procedures, as well as the usual means of laparoscopic ultrasonography (LUS) and visual inspection of the preoperative CT or MRI. The primary objective was to assess the feasibility of Hepataug, in terms of minimal disruption of the surgical workflow. The secondary objective was to assess the potential benefit of Hepataug, by subjective comparison with LUS. Results From July 2017 to March 2019, 17 consecutive patients were included in this study. AR was feasible in all procedures, with good correlation with LUS. However, for 2 patients, LUS did not reveal the location of the tumors. Hepataug gave a prediction of the tumor locations, which was confirmed and refined by careful inspection of the preoperative CT or MRI. Conclusion Hepataug showed a minimal disruption of the surgical workflow and can thus be feasibly used in real hepatectomy procedures. Thanks to its new mechanism of semi-automatic deformable alignment, Hepataug also showed a good agreement with LUS and visual CT or MRI inspection in subsurface tumor localization. Importantly, Hepataug yields reproducible results. It is easy to use and could be deployed in any existing operating room. Nevertheless, comparative prospective studies are needed to study its efficacy.
- 14 April 2020
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 24 (6) , 585-592
Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: results from the CLIMHET study group
Background Laparoscopic right hemicolectomy (LRHC) is increasingly performed for the treatment of right colon disease. Nevertheless, standardization of the surgical technique regarding the performance of intracorporeal (IC) or extracorporeal (EC) anastomosis is lacking. The purpose of this study was to compare short-term postoperative outcomes in patients who had laparoscopic right colectomy either with IC or EC. Methods This was a retrospective, non-randomized and multicenter study conducted from January 2005 to December 2015 on the CLIMHET study group cohort from five tertiary centers in France. Data were collected for all patients with LRHC to compare patient characteristics, intraoperative data and postoperative outcomes in terms of medical and surgical complications, duration of hospitalization and mortality. A multivariate analysis was performed to compare the results in the two groups. Results Of the 597 patients undergoing LRHC, 150 had IC and 447 had EC. The incidence of medical complications (cardiac, vascular, and pulmonary complications) was lower in the IC group than in the EC group (13 vs 20%, p = 0.049). This difference remained significant in multivariate analysis after adjusting to field characteristics and patient histories (p = 0.009). Additionally, a shorter hospital stay (7 vs 8 days, p = 0.003) was observed in the IC group as compared to the EC group. This difference remained significant in favor of the IC group in multivariate analysis (p = 0.029). There was no difference between the groups as regards: surgical complications (p = 0.76), time of mobilization (p = 0.93), reintervention rate (p = 1) and 90-day mortality (p = 0.47). Conclusions Our results show that IC anastomosis in LRHC is associated with fewer medical complications and shorter hospital stays compared to EC anastomosis.
- 14 April 2020
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 24 (6) , 585-592
Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: results from the CLIMHET study group
Background Laparoscopic right hemicolectomy (LRHC) is increasingly performed for the treatment of right colon disease. Nevertheless, standardization of the surgical technique regarding the performance of intracorporeal (IC) or extracorporeal (EC) anastomosis is lacking. The purpose of this study was to compare short-term postoperative outcomes in patients who had laparoscopic right colectomy either with IC or EC. Methods This was a retrospective, non-randomized and multicenter study conducted from January 2005 to December 2015 on the CLIMHET study group cohort from five tertiary centers in France. Data were collected for all patients with LRHC to compare patient characteristics, intraoperative data and postoperative outcomes in terms of medical and surgical complications, duration of hospitalization and mortality. A multivariate analysis was performed to compare the results in the two groups. Results Of the 597 patients undergoing LRHC, 150 had IC and 447 had EC. The incidence of medical complications (cardiac, vascular, and pulmonary complications) was lower in the IC group than in the EC group (13 vs 20%, p = 0.049). This difference remained significant in multivariate analysis after adjusting to field characteristics and patient histories (p = 0.009). Additionally, a shorter hospital stay (7 vs 8 days, p = 0.003) was observed in the IC group as compared to the EC group. This difference remained significant in favor of the IC group in multivariate analysis (p = 0.029). There was no difference between the groups as regards: surgical complications (p = 0.76), time of mobilization (p = 0.93), reintervention rate (p = 1) and 90-day mortality (p = 0.47). Conclusions Our results show that IC anastomosis in LRHC is associated with fewer medical complications and shorter hospital stays compared to EC anastomosis.
- 1 April 2020
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 157 (2) , 117-126
Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)
- 1 April 2020
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 157 (2) , 117-126
Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)